Liz Durkin, Manager of Revenue Cycle at Exact Sciences, explains why their team needed more than a data-entry prior authorization vendor. During a major Epic migration, they looked for a prior auth partner that understood clinical complexity, payer nuance, and high-pressure timelines without requiring constant handholding. This is what they looked for while considering Infinx, and why it mattered. | Infinx Healthcare

Exact Sciences CEO: $2.8 billion Genomic Health deal can yield $1.6 billion in revenue

Exact Sciences' shares pop on positive Cologuard trial results

MATCH Function